• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米索硝唑和WR-2721对小鼠肾脏辐射反应的影响

Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.

作者信息

Williams M V, Denekamp J

出版信息

Int J Radiat Oncol Biol Phys. 1983 Nov;9(11):1731-6. doi: 10.1016/0360-3016(83)90427-3.

DOI:10.1016/0360-3016(83)90427-3
PMID:6315650
Abstract

The radiation response of the mouse kidney has been assayed after a range of X ray doses given with or without the nitroimidazole misonidazole or the aminothiol WR-2721. Sensitization and protection of the kidney were investigated by comparing the X ray dose needed to achieve a particular level of injury in the presence or absence of the drug. Two functional assays and kidney weight at sacrifice were used to obtain dose response curves. Urine output and 51Chromium EDTA excretion were used as functional assays at 25 and 49 weeks after irradiation. They demonstrated no radio-sensitization by misonidazole with 1, 2 or 5 fractions of X rays. Significant radioprotection was seen when 400 mg kg 1 WR-2721 was given before single X ray doses (PF = 1.34). Similar radioprotection was observed when renal weight at 1 year after irradiation was used as the third assay of damage. These results confirm that the kidney responds as a well-oxygenated normal tissue with only a small protection being afforded against radiation injury by WR-2721.

摘要

在给予一系列X射线剂量后,对小鼠肾脏的辐射反应进行了测定,给药时或未给药时分别使用了硝基咪唑类药物米索硝唑或氨基硫醇WR-2721。通过比较在有或没有药物存在的情况下达到特定损伤水平所需的X射线剂量,研究了肾脏的增敏和保护作用。使用两种功能测定方法以及处死时的肾脏重量来获得剂量反应曲线。在照射后25周和49周,将尿量和51铬依地酸排泄用作功能测定方法。结果表明,米索硝唑对单次、两次或五次X射线照射均无放射增敏作用。当在单次X射线剂量前给予400 mg/kg 1的WR-2721时,观察到显著的放射保护作用(防护因子=1.34)。当将照射后1年时的肾脏重量用作第三种损伤测定方法时,观察到了类似的放射保护作用。这些结果证实,肾脏作为一个富氧的正常组织对辐射有反应,WR-2721对辐射损伤仅提供了很小的保护作用。

相似文献

1
Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.米索硝唑和WR-2721对小鼠肾脏辐射反应的影响
Int J Radiat Oncol Biol Phys. 1983 Nov;9(11):1731-6. doi: 10.1016/0360-3016(83)90427-3.
2
Modification of stromal radiosensitivity by misonidazole and WR-2721.
Br J Radiol. 1983 Aug;56(668):565-70. doi: 10.1259/0007-1285-56-668-565.
3
Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.联合使用WR-2721和甲硝唑对口腔辐射死亡综合征的改良
Br J Radiol. 1981 Nov;54(647):969-72. doi: 10.1259/0007-1285-54-647-969.
4
Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.实体小鼠肿瘤放疗期间的辐射防护与低氧增敏联合应用
Radiology. 1983 Jul;148(1):291-3. doi: 10.1148/radiology.148.1.6304811.
5
Time dependence of interaction of misonidazole and WR-2721.米索硝唑与WR-2721相互作用的时间依赖性。
Br J Radiol. 1983 Aug;56(668):592-5. doi: 10.1259/0007-1285-56-668-592.
6
Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):553-5. doi: 10.1016/0360-3016(82)90682-4.
7
Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation.
Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2099-107. doi: 10.1016/0360-3016(84)90208-6.
8
Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.肿瘤大小对S-2-(3-氨丙基氨基)乙硫代磷酸和米索硝唑改变肿瘤对环磷酰胺反应的影响。
Cancer Res. 1983 Jul;43(7):3050-6.
9
Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721.
Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1541-4. doi: 10.1016/0360-3016(84)90499-1.
10
[Responses to radiation of Ehrlich ascites tumor cells in the presence of YM-08310 (=WR-2721) and/or Ro-07-0582 (in vivo, in vitro assay)].[在存在YM-08310(=WR-2721)和/或Ro-07-0582的情况下艾氏腹水癌细胞对辐射的反应(体内、体外试验)]
Nihon Igaku Hoshasen Gakkai Zasshi. 1987 Feb 25;47(2):307-17.

引用本文的文献

1
All for one, though not one for all: team players in normal tissue radiobiology.众人同心,其利断金:正常组织放射生物学中的团队合作者。
Int J Radiat Biol. 2022;98(3):346-366. doi: 10.1080/09553002.2021.1941383. Epub 2021 Jul 1.
2
Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome.氨磷汀:关于其在接受化疗或放疗的癌症患者中作为细胞保护剂的临床现状及其在骨髓增生异常综合征中的潜在治疗应用的最新情况。
Drugs. 2001;61(5):641-84. doi: 10.2165/00003495-200161050-00012.
3
Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.
氨磷汀。对其药效学和药代动力学特性以及作为辐射防护剂和细胞毒性化学保护剂的治疗潜力的综述。
Drugs. 1995 Dec;50(6):1001-31. doi: 10.2165/00003495-199550060-00008.